Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.
RECRUITINGOBSERVATIONAL

Salivary Conductivity Screening for Dry Eye Disease and Sjögren's Syndrome

Saliva Conductivity as A Novel Screening Test for Dry Eye Disease and Sjögren's Syndrome

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

Dry eye disease, or keratoconjunctivitis sicca, is one of the most common diseases encountered at ophthalmologic clinics. Patient with dry eye disease commonly presented foreign body sensation, red eye, blurred vision, etc. Numerous treatments for dry eye disease are proposed due to its multifactorial etiology. Sjögren syndrome, which is one of the main etiologies of dry eye disease, is an autoimmune disease characterized by dysfunction of lacrimal and salivary glands. Although dry eye status can be easily examined by ocular surface staining, the methods quantifying salivary flow rate are hard to performed clinically, such as salivary gland scintigraphy and sialometry. Furthermore, disease activity could only rely on serum markers or salivary gland ultrasound. Recently, a portable device measuring salivary conductivity is believed to assess fluid status and renal function. Interestingly, the composition of salivary electrolytes in patients with Sjögren syndrome is different from those with other causes of hyposalivation. Thus, this study aims to evaluate whether salivary conductivity in combination with ocular surface staining can be a non-invasive diagnostic test for primary Sjögren syndrome among people with dry eye disease.

Who May Be Eligible (Plain English)

Who May Qualify: 1. Adults aged 20 and older 2. Patients with normal and dry eye syndrome Who Should NOT Join This Trial: 1. Hepatitis C 2. Acquired weakened immune system syndrome 3. Lymphoma 4. Intestinal amyloidosis 5. Open pulmonary tuberculosis 6. Graft-versus-host disease 7. Rheumatoid or lupus erythematosus and other autoimmune conditions (where your immune system attacks your own body)s 8. IgG4-related diseases 9. Head and neck radiation therapy 10. Glaucoma 11. History of infectious keratitis 12. History of ophthalmic surgery 13. Wear contact lenses in the month before the trial 14. Chew betel nuts or smoke within one month before the trial Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: 1. Adults aged 20 and older 2. Patients with normal and dry eye syndrome Exclusion Criteria: 1. Hepatitis C 2. Acquired immunodeficiency syndrome 3. Lymphoma 4. Intestinal amyloidosis 5. Open pulmonary tuberculosis 6. Graft-versus-host disease 7. Rheumatoid or lupus erythematosus and other autoimmune diseases 8. IgG4-related diseases 9. Head and neck radiation therapy 10. Glaucoma 11. History of infectious keratitis 12. History of ophthalmic surgery 13. Wear contact lenses in the month before the trial 14. Chew betel nuts or smoke within one month before the trial

Treatments Being Tested

DRUG

Carbomer Gel/Jelly

The drug is for dry eye syndrome by providing temporary relief from discomfort and irritation.

Locations (1)

Department of Ophthalmology, Chang Gung Memorial Hospital
Pizi, Taiwan